首页 › 基金 › Vestal Point Capital, LP › TARS
Vestal Point Capital, LP 对 TARS 的持仓历史
TARSUS PHARMACEUTICALS INC · 医疗保健
Vestal Point Capital, LP 在 Q3 2026 的 13F 申报中披露持有 TARS(TARSUS PHARMACEUTICALS INC)2,033,625 股,市值约 US$159.9M,约占其申报组合的 4.13%,在其申报持仓中市值排名第 9 位。 Vestal Point Capital, LP 最近 9 个申报季度中有 4 个季度披露了 TARS 持仓,最早可追溯至 Q3 2024。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
Vestal Point Capital, LP 对 TARS 的持仓演变
Vestal Point Capital, LP 于 Q3 2024 首次披露 TARS 持仓:230,000 股(约 US$7.6M)。 该持仓在 Q3 2026 达到峰值 2,033,625 股,市值约 US$159.9M。 在 4 次申报中,Vestal Point Capital, LP 2 次增持、0 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 2,033,625 股、市值约 US$159.9M,环比增持 983,625 股。。 持仓曾出现大幅变动:Q2 2026 增持约 425% (随后一个季度股价上涨 25%)、Q3 2026 增持约 94% (随后一个季度股价基本持平)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2024 | 230.00K | $7.56M | 新进 |
| Q1 2026 | 200.00K | $14.03M | 新进 |
| Q2 2026 | 1.05M | $66.09M | 增持 |
| Q3 2026 | 2.03M | $159.86M | 增持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 TARS 与 13F 数据
TARS(TARSUS PHARMACEUTICALS INC)属于医疗保健行业。我们追踪的基金中还有 44 只申报持有 TARS,申报仓位最大的包括:Deep Track Capital, LP (US$299.3M), RTW INVESTMENTS, LP (US$273.9M), Paradigm Biocapital Advisors LP (US$180.9M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 TARS 的基金
- Deep Track Capital, LP 3.81M 股 · $299.25M · Q3 2026
- RTW INVESTMENTS, LP 3.48M 股 · $273.88M · Q3 2026
- Paradigm Biocapital Advisors LP 2.30M 股 · $180.91M · Q3 2026
- TANG CAPITAL MANAGEMENT LLC 1.92M 股 · $150.75M · Q3 2026
- Bain Capital Life Sciences Investors, LLC 1.10M 股 · $86.17M · Q3 2026
- Frazier Life Sciences Management, L.P. 720.34K 股 · $56.63M · Q3 2026
- TCG Crossover Management, LLC 388.16K 股 · $30.51M · Q3 2026
- MPM BioImpact LLC 352.68K 股 · $27.72M · Q3 2026
- Rock Springs Capital Management LP 285.12K 股 · $22.41M · Q3 2026
更多关于 Vestal Point Capital, LP
常见问题
How long has Vestal Point Capital, LP held TARS?
Vestal Point Capital, LP has disclosed TARS holdings in 4 of the last 9 reported quarters, going back to Q3 2024.
What is Vestal Point Capital, LP's current position in TARS?
As of Q3 2026, Vestal Point Capital, LP holds 2.03M shares of TARS (TARSUS PHARMACEUTICALS INC), valued at $159.86M, representing 4.13% of its reported portfolio and ranking #9.
Has Vestal Point Capital, LP been buying or selling TARS?
In the latest 13F filing (Q3 2026), Vestal Point Capital, LP increased its position in TARS. The position peaked in Q3 2026 at 2.03M shares.
Which other funds hold TARS?
Other major institutional holders of TARS include Deep Track Capital, LP, RTW INVESTMENTS, LP, Paradigm Biocapital Advisors LP, among 44 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.